| Literature DB >> 35454678 |
Sonia Nieto-Ortega1, Idoia Olabarrieta1, Eduardo Saitua1, Gorka Arana2, Giuseppe Foti1, Ángela Melado-Herreros1.
Abstract
A handheld near infrared (NIR) spectrometer was used for on-site determination of the fatty acids (FAs) composition of industrial fish oils from fish by-products. Partial least square regression (PLSR) models were developed to correlate NIR spectra with the percentage of saturated fatty acids (SFAs), monounsaturated fatty acids (MUFAs), polyunsaturated fatty acids (PUFAs) and, among them, omega-3 (ω-3) and omega-6 (ω-6) FAs. In a first step, the data were divided into calibration validation datasets, obtaining good results regarding R2 values, root mean square error of prediction (RMSEP) and bias. In a second step, all these data were used to create a new calibration, which was uploaded to the handheld device and tested with an external validation set in real time. Evaluation of the external test set for SFAs, MUFAs, PUFAs and ω-3 models showed promising results, with R2 values of 0.98, 0.97, 0.97 and 0.99; RMSEP (%) of 0.94, 1.71, 1.11 and 0.98; and bias (%) values of -0.78, -0.12, -0.80 and -0.67, respectively. However, although ω-6 models achieved a good R2 value (0.95), the obtained RMSEP was considered high (2.08%), and the bias was not acceptable (-1.76%). This was corrected by applying bias and slope correction (BSC), obtaining acceptable values of R2 (0.95), RMSEP (1.09%) and bias (-0.05%). This work goes a step further in the technology readiness level (TRL) of handheld NIR sensor solutions for the fish by-product recovery industry.Entities:
Keywords: chemometrics; circular economy; fish oil industry; lipid profile; no-waste; omega-3; recovery; reuse; smart sensors
Year: 2022 PMID: 35454678 PMCID: PMC9024635 DOI: 10.3390/foods11081092
Source DB: PubMed Journal: Foods ISSN: 2304-8158
Samples of oil mixtures used in each dataset.
| Calibration Set | Validation Set | External Validation Set | |
|---|---|---|---|
| Number of mixtures | 172 | 97 | 29 |
| Oils and supplements used | A, B, C, D, E, F and G | B, E, F, G and H | B, E, F, I, Supplement A |
Identified FAs in each category.
| FAs Group | Fatty Acids |
|---|---|
| SFAs | Myristic (14:0), Palmitic (16:0), Stearic (18:0), Arachidic (20:0) |
| MUFAs | Palmitoleic (16:1), Oleic (18:1), Gadoleic (20:1), Erucic (22:1) |
| PUFAs | Linoleic (18:2), Gamma-linolenic (18:3), Stearidonic (18:4), Arachidonic (20:4), EPA (20:5), Clupanodonic (22:5), DHA (22:6). |
| ω-3 | Alpha-linoleic (18:3), Stearidonic (18:4), EPA (20:5), Clupanodonic (22:5), DHA (22:6) |
| ω-6 | Linoleic (18:2), Arachidonic (20:4) |
SFAs: saturated fatty acids, MUFAs: monounsaturated fatty acids, PUFAs: polyunsaturated fatty acids, ω-3: omega-3 fatty acids, ω-6: omega-6 fatty acids.
Composition (%) of the initial oils with their standard deviation.
| Oils | SFAs | MUFAs | PUFAs | ω-3 | ω-6 |
|---|---|---|---|---|---|
| A | 27.84 ± 0.32 | 42.05 ± 0.08 | 30.11 ± 0.25 | 27.50 ± 0.23 | 2.61 ± 0.03 |
| B | 14.26 ± 0.08 | 53.76 ± 0.12 | 31.98 ± 0.05 | 14.18 ± 0.05 | 17.80 ± 0.02 |
| C | 29.27 ± 0.30 | 25.60 ± 0.14 | 45.13 ± 0.30 | 42.24 ± 0.31 | 2.90 ± 0.00 |
| D | 17.47 ± 0.19 | 49.26 ± 0.03 | 33.27 ± 0.21 | 17.70 ± 0.13 | 15.57 ± 0.09 |
| E | 21.09 ± 0.26 | 44.94 ± 0.52 | 33.98 ± 0.30 | 22.27 ± 0.10 | 11.70 ± 0.32 |
| F | 29.66 ± 0.19 | 25.58 ± 0.09 | 44.76 ± 0.15 | 41.88 ± 0.14 | 2.89 ± 0.02 |
| G | 17.51 ± 0.21 | 49.10 ± 0.16 | 33.39 ± 0.07 | 17.87 ± 0.05 | 15.52 ± 0.03 |
| H | 18.51 ± 0.40 | 48.75 ± 0.19 | 32.74 ± 0.22 | 17.43 ± 0.14 | 15.31 ± 0.07 |
| I | 18.10 ± 0.08 | 49.18 ± 0.31 | 32.73 ± 0.24 | 17.50 ± 0.08 | 15.23 ± 0.17 |
| Supplement A | 14.34 ± 0.02 | 56.56 ± 0.30 | 29.10 ± 0.32 | 14.25 ± 0.39 | 14.85 ± 0.08 |
| Supplement B | 29.50 ± 0.02 | 25.32 ± 0.03 | 45.19 ± 0.05 | 42.08 ± 0.07 | 3.11 ± 0.01 |
For each sample, three replications were performed. SFAs: saturated fatty acids, MUFAs: monounsaturated fatty acids, PUFAs: polyunsaturated fatty acids, ω-3: omega-3 fatty acids, ω-6: omega-6 fatty acids.
Results of the characterization of all the samples.
| Dataset |
| Mean ± SD (%) | Minimum (%) | Maximum (%) | ||
|---|---|---|---|---|---|---|
| SFAs | 1st Step | Calibration | 172 | 22.0 ± 3.8 | 14.3 | 29.7 |
| Validation | 97 | 24.1 ± 3.8 | 14.4 | 29.7 | ||
| 2nd Step | Calibration | 269 | 22.7 ± 3.8 | 14.3 | 29.7 | |
| External Validation | 29 | 20.5 ± 4.8 | 14.3 | 29.7 | ||
| MUFAs | 1st Step | Calibration | 172 | 41.4 ± 6.9 | 25.6 | 53.8 |
| Validation | 97 | 37.2 ± 7.4 | 25.6 | 53.6 | ||
| 2nd Step | Calibration | 269 | 40.1 ± 7.1 | 25.6 | 53.8 | |
| External Validation | 29 | 43.7 ± 9.2 | 25.3 | 56.6 | ||
| PUFAs | 1st Step | Calibration | 172 | 36.5 ± 3.6 | 30.1 | 45.1 |
| Validation | 97 | 38.6 ± 3.6 | 32.0 | 44.8 | ||
| 2nd Step | Calibration | 269 | 37.2 ± 3.6 | 30.1 | 45.1 | |
| External Validation | 29 | 35.8 ± 4.4 | 29.1 | 45.2 | ||
| ω-3 | 1st Step | Calibration | 172 | 26.2 ± 6.9 | 14.2 | 42.2 |
| Validation | 97 | 30.0 ± 7.4 | 14.3 | 41.9 | ||
| 2nd Step | Calibration | 269 | 27.4 ± 7.0 | 14.2 | 42.2 | |
| External Validation | 29 | 23.7 ± 9.0 | 14.2 | 42.1 | ||
| ω-6 | 1st Step | Calibration | 172 | 10.3 ± 3.8 | 2.6 | 17.8 |
| Validation | 97 | 8.6 ± 3.9 | 2.9 | 17.7 | ||
| 2nd Step | Calibration | 269 | 9.8 ± 3.8 | 2.6 | 17.8 | |
| External Validation | 29 | 12.1 ± 4.7 | 2.9 | 17.8 |
n: number of samples, SD: standard deviation, SFAs: saturated fatty acids, MUFAs: monounsaturated fatty acids, PUFAs: polyunsaturated fatty acids, ω-3: omega-3 fatty acids, ω-6: omega-6 fatty acids.
Principal statistics of the five models developed in the first step.
| X Preprocessing | Y Preprocessing | LV | R2 | RMSE (%) | Bias (%) | ||
|---|---|---|---|---|---|---|---|
| SFAs | CV | 2nd derivative (order 2, window 5) + Mean Center | Mean Center | 5 | 0.98 | 0.57 | −2 × 10−3 |
| Validation | 0.98 | 0.68 | −0.40 | ||||
| MUFAs | CV | SNV + Mean Center | Mean Center | 3 | 0.99 | 0.74 | −3 × 10−4 |
| Validation | 0.97 | 1.27 | 0.25 | ||||
| PUFAs | CV | SNV + 2nd derivative (order 2, window 15) + Mean Center | Mean Center | 5 | 0.97 | 0.65 | 2 × 10−4 |
| Validation | 0.96 | 0.85 | −0.49 | ||||
| ω-3 | CV | SNV + 2nd derivative (order 2, window 15) + Mean Center | Mean Center | 6 | 0.99 | 0.48 | −2 × 10−3 |
| Validation | 0.99 | 0.60 | −0.26 | ||||
| ω-6 | CV | MSC (using the mean of the spectra as reference) + 1st derivative (order 2 window 5) + Mean Center | Mean Center | 6 | 0.96 | 0.78 | 0.02 |
| Validation | 0.95 | 0.90 | −0.34 |
LV: latent variables, CV: cross-validation, SNV: standard normal variate, MSC: multiplicative scatter correction, RMSE: root mean square error, SFAs: saturated fatty acids, MUFAs: monounsaturated fatty acids, PUFAs: polyunsaturated fatty acids, ω-3: omega-3 fatty acids, ω-6: omega-6 fatty acids.
Principal statistics calculated for the five models developed in the second step.
| X Pretreatment | Y Pretreatment | LV | R2 | RMSE (%) | Bias (%) | ||
|---|---|---|---|---|---|---|---|
| SFAs | CV | 2nd derivative (order 2, window 5) + Mean Center | Mean Center | 5 | 0.98 | 0.60 | −4 × 10−3 |
| External validation | 0.98 | 0.94 | −0.78 | ||||
| MUFAs | CV | SNV + Mean Center | Mean Center | 3 | 0.99 | 0.77 | 5 × 10−4 |
| External validation | 0.97 | 1.71 | −0.12 | ||||
| PUFAs | CV | SNV + 2nd derivative (order 2, window 15) + Mean Center | Mean Center | 5 | 0.97 | 0.65 | 2 × 10−3 |
| External validation | 0.97 | 1.11 | −0.80 | ||||
| ω-3 | CV | SNV + 2nd derivative (order 2, window 15) + Mean Center | Mean Center | 6 | 0.99 | 0.71 | −5 × 10−6 |
| External validation | 0.99 | 0.98 | −0.67 | ||||
| ω-6 | CV | MSC (using the mean of the spectra as reference) + 1st derivative (order 2 window 5) + Mean Center | Mean Center | 6 | 0.96 | 0.74 | −1 × 10−4 |
| External validation | 0.95 | 2.09 | −1.76 |
LV: latent variables, CV: cross-validation, SNV: standard normal variate, MSC: multiplicative scatter correction, RMSE: root mean square error, SFAs: saturated fatty acids, MUFAs: monounsaturated fatty acids, PUFAs: polyunsaturated fatty acids, ω-3: omega-3 fatty acids, ω-6: omega-6 fatty acids.
Figure 1Results of the external validation of the PLSR for prediction of ω-6 before (a) and after (b) bias and slope correction.
Figure 2Raw spectra of the oil mixtures used during the experiment.
Figure 3LV1 and LV2 of the second-step models. (a,b) SFAs, (c,d) MUFAs, (e,f) PUFAs, (g,h) ω-3, (i,j) ω-6.